🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

229 results for “Ovid” Clear

  1. Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine

    Moderna Biotech Spain

    SARS-CoV-2 infection

    approved small molecule active

    1 trial

  2. Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  3. XALKORI 200 mg hard capsules, XALKORI 250 mg hard capsules, Crizotinib 200 mg capsules, Crizotinib 250 mg capsules

    Pfizer Australia Pty Ltd

    This Master Protocol for Crizotinib Continuation Sub-Studies has been designed to provide continued treatment access for eligible participants who continue to derive clinical benefit from study intervention in a Pfizer sponsored crizotinib parent study that will be closed

    approved small molecule active

    1 trial

  4. [68Ga]FAPI-46

    Disc Medicine

    post-acute sequelae of COVID-19

    approved small molecule active

    1 trial

  5. COVID Convalescent Plasma

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    mab active

    1 trial

  6. Favipiravir

    The First People's Hospital of Lianyungang

    COVID-19

    small molecule active

    1 trial

  7. Low dose Radiotherapy

    United Therapeutics Europe Ltd

    Covid19

    other completed

    1 trial

  8. Nitazoxanide Tablets

    Vera Therapeutics

    COVID-19

    small molecule completed

    1 trial

  9. RT-PCR Test

    BRIGHT MINDS BIOSCIENCES INC.

    COVID-19

    other completed

    1 trial

  10. Recombinant COVID-19 Vaccine (Sf9 Cell)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    mab completed

    1 trial

  11. SA58 Nasal Spray

    Sinovac Research and Development Co.,

    COVID-19

    small molecule active

    2 trials

  12. Sperm test

    The First People's Hospital of Lianyungang

    Covid19

    other active

    1 trial

  13. carotid-femoral pulse-wave velocity

    Structure Therapeutics

    Covid19

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources